{"id":877804,"date":"2025-08-21T07:05:43","date_gmt":"2025-08-21T11:05:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/"},"modified":"2025-08-21T07:05:43","modified_gmt":"2025-08-21T11:05:43","slug":"insmed-to-present-at-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/","title":{"rendered":"Insmed To Present at September Investor Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">BRIDGEWATER, N.J.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 21, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>Wells <span class=\"xn-location\">Fargo<\/span> 2025 Healthcare Conference in <span class=\"xn-location\">Boston<\/span>, on <span class=\"xn-chron\">Friday, September 5, 2025<\/span>, at <span class=\"xn-chron\">8:00 a.m. ET<\/span>.<\/li>\n<li>\n          <span class=\"xn-person\">Morgan Stanely<\/span> 23<sup>rd<\/sup> Annual Global Healthcare Conference in <span class=\"xn-location\">New York<\/span>, on <span class=\"xn-chron\">Tuesday, September 9, 2025<\/span>, at <span class=\"xn-chron\">4:50 p.m. ET<\/span>.<\/li>\n<\/ul>\n<p>These events will be webcast live and can be accessed by visiting the investor relations section of the Company&#8217;s website at\u00a0<b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492689-1&amp;h=187992374&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4181846-1%26h%3D389461705%26u%3Dhttps%253A%252F%252Finsmed.com%252F%26a%3Dwww.insmed.com&amp;a=www.insmed.com\" target=\"_blank\" rel=\"nofollow\">www.insmed.com<\/a><\/b>. Webcasts will be archived for a period of 30 days following the conclusion of the live events.<\/p>\n<p>\n        <b>About Insmed<\/b>\n      <\/p>\n<p>Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed&#8217;s most advanced programs are in pulmonary and in\ufb02ammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company&#8217;s early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.<\/p>\n<p>Headquartered in <span class=\"xn-location\">Bridgewater, New Jersey<\/span>, Insmed has offices and research locations throughout <span class=\"xn-location\">the United States<\/span>, <span class=\"xn-location\">Europe<\/span>, and <span class=\"xn-location\">Japan<\/span>. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 <i>Science<\/i> Top Employer. Visit <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492689-1&amp;h=1427476989&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4390270-1%26h%3D1626118123%26u%3Dhttp%253A%252F%252Fwww.insmed.com%252F%26a%3Dwww.insmed.com&amp;a=www.insmed.com\" target=\"_blank\" rel=\"nofollow\">www.insmed.com<\/a><\/b> to learn more or follow us on <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492689-1&amp;h=592433883&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Finsmed&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a><\/b>, <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492689-1&amp;h=190672758&amp;u=https%3A%2F%2Fwww.instagram.com%2FInsmed%2F&amp;a=Instagram\" target=\"_blank\" rel=\"nofollow\">Instagram<\/a><\/b>, <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492689-1&amp;h=3180229355&amp;u=https%3A%2F%2Fwww.youtube.com%2F%40insmed&amp;a=YouTube\" target=\"_blank\" rel=\"nofollow\">YouTube<\/a><\/b>, and <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4492689-1&amp;h=202182780&amp;u=https%3A%2F%2Fx.com%2FInsmed&amp;a=X\" target=\"_blank\" rel=\"nofollow\">X<\/a><\/b>.<\/p>\n<p>\n        <b>Contact:<br \/><\/b>Investors:<br \/><span class=\"xn-person\">Bryan Dunn<\/span><br \/>Vice President, Investor Relations<br \/>(646) 812-4030<br \/><a href=\"mailto:investor.relations@insmed.com\" target=\"_blank\" rel=\"nofollow\">investor.relations@insmed.com<\/a><\/p>\n<p>Media:<br \/><span class=\"xn-person\">Claire Mulhearn<\/span><br \/>Vice President, Corporate Communications<br \/>(862) 842-6819<br \/><a href=\"mailto:media@insmed.com\" target=\"_blank\" rel=\"nofollow\">media@insmed.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder9594\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg\" title=\"Insmed-Logo-Purple (PRNewsfoto\/Insmed Incorporated)\" alt=\"Insmed-Logo-Purple (PRNewsfoto\/Insmed Incorporated)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY55986&amp;sd=2025-08-21\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/insmed-to-present-at-september-investor-conferences-302535055.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/insmed-to-present-at-september-investor-conferences-302535055.html<\/a><\/p>\n<p>SOURCE  Insmed Incorporated<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY55986&amp;Transmission_Id=202508210700PR_NEWS_USPR_____NY55986&amp;DateId=20250821\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire BRIDGEWATER, N.J. , Aug. 21, 2025 \/PRNewswire\/ &#8212; Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: Wells Fargo 2025 Healthcare Conference in Boston, on Friday, September 5, 2025, at 8:00 a.m. ET. Morgan Stanely 23rd Annual Global Healthcare Conference in New York, on Tuesday, September 9, 2025, at 4:50 p.m. ET. These events will be webcast live and can be accessed by visiting the investor relations section of the Company&#8217;s website at\u00a0www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Insmed To Present at September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-877804","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insmed To Present at September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insmed To Present at September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire BRIDGEWATER, N.J. , Aug. 21, 2025 \/PRNewswire\/ &#8212; Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: Wells Fargo 2025 Healthcare Conference in Boston, on Friday, September 5, 2025, at 8:00 a.m. ET. Morgan Stanely 23rd Annual Global Healthcare Conference in New York, on Tuesday, September 9, 2025, at 4:50 p.m. ET. These events will be webcast live and can be accessed by visiting the investor relations section of the Company&#8217;s website at\u00a0www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events. About &hellip; Continue reading &quot;Insmed To Present at September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-21T11:05:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Insmed To Present at September Investor Conferences\",\"datePublished\":\"2025-08-21T11:05:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/\"},\"wordCount\":325,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2544698\\\/Insmed_Incorporated_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/\",\"name\":\"Insmed To Present at September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2544698\\\/Insmed_Incorporated_Logo.jpg\",\"datePublished\":\"2025-08-21T11:05:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2544698\\\/Insmed_Incorporated_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2544698\\\/Insmed_Incorporated_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insmed-to-present-at-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insmed To Present at September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insmed To Present at September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Insmed To Present at September Investor Conferences - Market Newsdesk","og_description":"PR Newswire BRIDGEWATER, N.J. , Aug. 21, 2025 \/PRNewswire\/ &#8212; Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: Wells Fargo 2025 Healthcare Conference in Boston, on Friday, September 5, 2025, at 8:00 a.m. ET. Morgan Stanely 23rd Annual Global Healthcare Conference in New York, on Tuesday, September 9, 2025, at 4:50 p.m. ET. These events will be webcast live and can be accessed by visiting the investor relations section of the Company&#8217;s website at\u00a0www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events. About &hellip; Continue reading \"Insmed To Present at September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-21T11:05:43+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Insmed To Present at September Investor Conferences","datePublished":"2025-08-21T11:05:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/"},"wordCount":325,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/","name":"Insmed To Present at September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg","datePublished":"2025-08-21T11:05:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2544698\/Insmed_Incorporated_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insmed-to-present-at-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Insmed To Present at September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=877804"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877804\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=877804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=877804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=877804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}